The FDA has finalized important guidance offering recommendations on the information about predetermined change control plans (PCCPs) to provide in marketing submissions for medical devices that include artificial intelligence (AI)-enabled device software functions (DSFs). A PCCP submitted to the FDA by a device sponsor should “described the planned AI-DSF modifications, the ... Read More